The FDA got it right when they approved TMS therapy for adolescent depression (kids aged 15 and older). TMS is one of the most effective treatments for resistant depression. The decision to approve this treatment for kids is an absolute game-changer and will save many young lives. This article describes the dramatic impact of the FDA’s approval and covers research that shows TMS for kids to be safe, well-tolerated, and effective.
Read MoreWhat is really happening behind the scenes at insurance companies to block patients from more expensive (and sometimes more effective) medical treatments? This article discusses the need for transparency and reform of the involvement of “hired gun” physicians in routine denials of medical coverage.
Read MoreThe Strengthening Behavioral Health Parity Act (SBHPA) was a major step toward mental health parity in the US. Before its passage, many Americans, especially those with ERISA-based health plans, were not protected by federal and state mental health parity laws. This article describes the history of mental health parity and what people can do to advocate for themselves.
Read MoreThis article has been archived as it is no longer has current information due to the passage of the Strengthening Behavioral Health Parity Act (SBHPA) on 12.27.2020. For an up-to-date article on mental health parity and the SBHPA, please see my article titled, “The Strengthening Behavioral Health Parity Act (SBHPA): An Enormous Step Forward in Mental Health Parity.”
Read More
